| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | VOLL MARK Chief Financial Officer | Purchase | +25,000 | +21.30%142,380 | $0.79 | $19,690 | View SEC filing | |
| 2026-03-24 | Marton Laurence Director | Purchase | +14,580 | +100.00%14,580 | N/A | N/A | View SEC filing | |
| 2026-03-24 | Bagai Shaun Chief Executive Officer | Purchase | +36,450 | +12.61%325,507 | N/A | N/A | View SEC filing | |
| 2026-03-24 | VOLL MARK Chief Financial Officer | Purchase | +145,800 | +100.00%145,800 | N/A | N/A | View SEC filing | |
| 2026-01-22 | Agah Ramtin Chief Medical Officer | Purchase | +10,000 | +1.27%798,460 | $1.00 | $9,975 | View SEC filing | |
| 2026-01-05 | Agah Ramtin Chief Medical Officer | Purchase | +9,795 | +1.26%788,460 | $0.86 | $8,424 | View SEC filing | |
| 2026-01-02 | Agah Ramtin Chief Medical Officer | Purchase | +205 | +0.03%778,665 | $0.83 | $169 | View SEC filing | |
| 2025-12-22 | Bagai Shaun Chief Executive Officer | Purchase | +5,000 | +1.49%340,040 | $0.90 | $4,507 | View SEC filing | |
| 2025-12-19 | Bagai Shaun Chief Executive Officer | Purchase | +5,000 | +1.51%335,040 | $0.85 | $4,262 | View SEC filing | |
| 2025-12-17 | Agah Ramtin Chief Medical Officer | Purchase | +12,000 | +1.57%778,460 | $0.85 | $10,200 | View SEC filing | |
| 2025-12-08 | Agah Ramtin Chief Medical Officer | Purchase | +10,000 | +1.32%766,460 | $0.96 | $9,600 | View SEC filing | |
| 2025-11-24 | Agah Ramtin Chief Medical Officer | Purchase | +22,000 | +3.00%756,460 | $0.80 | $17,600 | View SEC filing | |
| 2025-08-26 | Bagai Shaun Chief Executive Officer | Purchase | +10,000 | +3.12%330,040 | $0.93 | $9,297 | View SEC filing | |
| 2025-06-09 | Agah Ramtin Chief Medical Officer | Purchase | +21,000 | +2.94%734,460 | $1.40 | $29,400 | View SEC filing | |
| 2025-04-17 | Agah Ramtin Chief Medical Officer | Purchase | +15,000 | +1.37%1,113,460 | $0.90 | $13,500 | View SEC filing | |
| 2025-04-16 | Bagai Shaun Chief Executive Officer | Purchase | +7,500 | +2.40%320,040 | $0.91 | $6,821 | View SEC filing | |
| 2025-04-14 | Agah Ramtin Chief Medical Officer | Purchase | +20,000 | +1.85%1,098,460 | $0.80 | $16,000 | View SEC filing | |
| 2025-04-10 | Kocak Ron VP Controller and PAO | Purchase | +12,595 | +100.00%12,595 | $0.79 | $10,011 | View SEC filing | |
| 2025-04-10 | Agah Ramtin Chief Medical Officer | Purchase | +30,000 | +2.86%1,078,460 | $0.81 | $24,399 | View SEC filing | |
| 2025-04-10 | Bagai Shaun Chief Executive Officer | Purchase | +10,000 | +3.31%312,540 | $0.83 | $8,300 | View SEC filing | |
| 2025-04-09 | Marton Laurence Director | Purchase | +12,050 | +35.83%45,684 | $0.85 | $10,218 | View SEC filing | |
| 2025-04-09 | Agah Ramtin Chief Medical Officer | Purchase | +26,000 | +2.54%1,048,460 | $0.84 | $21,840 | View SEC filing | |
| 2025-04-08 | Bagai Shaun Chief Executive Officer | Purchase | +10,000 | +3.42%302,540 | $0.83 | $8,300 | View SEC filing | |
| 2024-01-30 | Agah Ramtin Chief Medical Officer | Purchase | +81,966 | +1265.49%88,443 | N/A | N/A | View SEC filing | |
| 2024-01-30 | Spiegel Robert J. Director | Purchase | +81,966 | +100.00%81,966 | N/A | N/A | View SEC filing |
1-25 of 31